Upregulation of HIF-1α, VEGF, and IL-8 (A) was
associated with high HIF-1α/ARNT complexes, low levels of
HIF-1α inhibitors (IGFBP3, BNIP3, BNIP3L, and EGLN2), and low
EGLN2/HIF-1α complexes in subclass A HCC (B).
(C) Suppression of Ras downstream effectors MEK (UO126
[UO]) and AKT (LY294002 [LY]) led to downregulation of HIF-1α,
VEGF, and IL-8 in Focus hepatoma cell lines. (D) Reactivation
of HIF-1α inhibitors and EGLN2 by Zebularine (Zeb) reduced
HIF-1α, VEGF, and IL-8 expression in Focus hepatoma cell lines.
Equivalent results were obtained in SNU-387 and 7703 hepatoma cell lines
(data not shown).